WINTON GROUP Ltd Trims Stake in Vir Biotechnology, Inc. $VIR
MarketBeat
WINTON GROUP Ltd significantly reduced its stake in Vir Biotechnology Inc. (NASDAQ:VIR) by 58.3% in the second quarter, selling over 214,000 shares. Despite this reduction, institutional ownership remains high at 65.32%, with major investors like BlackRock and ARCH Venture Management increasing their positions. Vir Biotechnology reported strong quarterly earnings, beating analyst estimates with an EPS of $0.47 and revenue of $238.95 million, maintaining a "Moderate Buy" consensus rating among an
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.